|
Volumn 14, Issue 12, 2007, Pages 1172-1177
|
Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: An 8 year randomised study
|
Author keywords
Albendazole; Neurocysticercosis
|
Indexed keywords
ALBENDAZOLE;
ANTICONVULSIVE AGENT;
ANTIPARASITIC AGENT;
CARBAMAZEPINE;
DEXAMETHASONE;
PHENYTOIN;
PLACEBO;
VALPROIC ACID;
ADULT;
ARTICLE;
BRAIN DAMAGE;
BRAIN DISEASE;
CLINICAL EVALUATION;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
FEMALE;
FOLLOW UP;
HEADACHE;
HOSPITAL READMISSION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NEUROCYSTICERCOSIS;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEIZURE;
SENSORY SYSTEM;
TONIC CLONIC SEIZURE;
VOMITING;
ADULT;
ALBENDAZOLE;
ANTHELMINTICS;
ANTIPARASITIC AGENTS;
BRAIN;
ELECTROENCEPHALOGRAPHY;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW-UP STUDIES;
HOSPITALIZATION;
HUMANS;
MALE;
NEUROCYSTICERCOSIS;
SEIZURES;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 36048962061
PISSN: 09675868
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jocn.2006.09.004 Document Type: Article |
Times cited : (39)
|
References (15)
|